Literature DB >> 708548

Clearance of neostigmine from the circulation during the antagonism of neuromuscular block.

N E Williams, T N Calvey, K Chan.   

Abstract

The plasma concentration of neostigmine was measured in five patients during the antagonism of neuromuscular block. The concentration of the drug decreased rapidly between 2 and 5 min after administration, and then more slowly. Detectable concentrations of neostigmine were present in plasma after 60 min. In the five patients the distribution half-life of neostigmine was less than 1 min; the elimination half-life ranged from 15.4 to 30.1 min.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708548     DOI: 10.1093/bja/50.10.1065

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  6 in total

Review 1.  Clinical pharmacokinetics of cholinesterase inhibitors.

Authors:  S M Aquilonius; P Hartvig
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

2.  Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis.

Authors:  S M Aquilonius; S A Eckernäs; P Hartvig; B Lindström; P O Osterman; E Stålberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

3.  Effects of neostigmine and pyridostigmine on serum cholinesterase activity.

Authors:  R K Mirakhur; T D Lavery; L P Briggs; R S Clarke
Journal:  Can Anaesth Soc J       Date:  1982-01

4.  Effects of neostigmine and pyridostigmine on serum cholinesterase activity.

Authors:  R K Mirakhur; R S Clarke; P S Collier
Journal:  Can Anaesth Soc J       Date:  1982-05

5.  Assessment of neuromuscular blockade by electromyography: a review.

Authors:  T N Calvey
Journal:  J R Soc Med       Date:  1984-01       Impact factor: 18.000

6.  Effects of Sugammadex and Neostigmine on Renal Biomarkers.

Authors:  Yasemin Isik; Onur Palabiyik; Bilal Muhammed Cegin; Ugur Goktas; Ismail Kati
Journal:  Med Sci Monit       Date:  2016-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.